5000 employees
Rempex Pharmaceuticals engages in the discovery and development of antibacterial drugs for antibiotic resistance.
2011
$68M
from 5 investors over 5 rounds
Rempex Pharmaceuticals raised $68M on November 9, 2011
Investors: Frazier Healthcare Partners, OrbiMed Advisors, SV Life Sciences, Adams Street Partners and Vivo Capital